Newron Pharmaceuticals S.p.A.

PRESS RELEASE

published on 10/02/2023 at 07:00, 2 years 6 months ago

Newron appoints Margarita Chavez as board advisor
PRESS RELEASE

published on 08/04/2023 at 07:00, 2 years 8 months ago

Newron announces H1 2023 results and provides R&D update
PRESS RELEASE

published on 05/15/2023 at 07:00, 2 years 10 months ago

Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
PRESS RELEASE

published on 05/03/2023 at 07:00, 2 years 11 months ago

Newron to present at the 34th CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
PRESS RELEASE

published on 05/02/2023 at 07:00, 2 years 11 months ago

Newron announces Senior Management Team changes
PRESS RELEASE

published on 04/18/2023 at 12:15, 2 years 11 months ago

Newron announces AGM 2023 results
PRESS RELEASE

published on 03/28/2023 at 12:30, 3 years ago

Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
PRESS RELEASE

published on 03/20/2023 at 07:00, 3 years ago

Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia
PRESS RELEASE

published on 03/17/2023 at 07:00, 3 years ago

Newron to present at the 31st European Congress of Psychiatry
PRESS RELEASE

published on 03/14/2023 at 07:00, 3 years ago

Newron announces 2022 financial results and provides outlook for 2023

Published on 04/09/2026 at 19:15, 2 hours 44 minutes ago

Murchison Minerals Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Published on 04/09/2026 at 16:00, 5 hours 59 minutes ago

Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 7 hours 19 minutes ago

Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 7 hours 59 minutes ago

Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 8 hours 29 minutes ago

Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate

View all ACCESSWIRE

Published on 04/09/2026 at 21:01, 57 minutes ago

GEVELOT S.A.: PRESS RELEASE CLOSING OF 2025 ACCOUNTS
Published on 04/09/2026 at 20:03, 1 hour 55 minutes ago

Annual General Meeting approves all proposals
Published on 04/09/2026 at 18:15, 3 hours 43 minutes ago

REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:59, 5 hours 59 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/09/2026 at 15:57, 6 hours 1 minute ago

Cairn Homes Plc: Holding(s) in Company

View all EQS

Published on 04/09/2026 at 18:35, 3 hours 24 minutes ago

Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 17:35, 4 hours 24 minutes ago

SUEZ - FY 2025
Published on 04/09/2026 at 15:57, 6 hours 1 minute ago

Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 14 hours 59 minutes ago

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 1 day 3 hours ago

Publication of the 2025 Universal Registration Document

View all LES ECHOS COMFI WIRE

News